AbCellera Biologics, Inc. (ABCL)
13.78
+0.04
(+0.29%)
USD |
NASDAQ |
Oct 05, 16:00
13.89
+0.11
(+0.80%)
Pre-Market: 08:38
AbCellera Biologics EPS Diluted (Quarterly) : -0.1814 for June 30, 2026
EPS Diluted (Quarterly) Chart
Historical EPS Diluted (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | -0.1814 |
| March 31, 2026 | -0.1424 |
| December 31, 2025 | -0.0298 |
| September 30, 2025 | -0.1911 |
| June 30, 2025 | -0.1163 |
| March 31, 2025 | -0.1532 |
| December 31, 2024 | -0.1157 |
| September 30, 2024 | -0.1733 |
| June 30, 2024 | -0.1255 |
| March 31, 2024 | -0.1387 |
| December 31, 2023 | -0.1626 |
| September 30, 2023 | -0.0988 |
| June 30, 2023 | -0.1057 |
| March 31, 2023 | -0.1394 |
| December 31, 2022 | -0.1042 |
| September 30, 2022 | 0.0843 |
| June 30, 2022 | -0.0238 |
| Date | Value |
|---|---|
| March 31, 2022 | 0.5412 |
| December 31, 2021 | 0.1929 |
| September 30, 2021 | -0.0766 |
| June 30, 2021 | -0.0085 |
| March 31, 2021 | 0.366 |
| December 31, 2020 | 0.4341 |
| September 30, 2020 | -0.0175 |
| June 30, 2020 | 0.0299 |
| March 31, 2020 | 0.00 |
| December 31, 2019 | 0.00 |
| September 30, 2019 | 0.00 |
| June 30, 2019 | 0.00 |
| March 31, 2019 | 0.00 |
| December 31, 2018 | 0.00 |
| September 30, 2018 | 0.00 |
| June 30, 2018 | 0.00 |
| March 31, 2018 | 0.00 |
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| MindWalk Holdings Corp. | -0.0931 |
| Repligen Corp. | 0.0884 |
| Bio-Techne Corp. | 0.348 |
| Aurinia Pharmaceuticals, Inc. | 0.2802 |
| BioLife Solutions, Inc. | 0.915 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -55.43M |
| Revenue (Quarterly) | 4.05M |
| Total Expenses (Quarterly) | 59.48M |
| Enterprise Value | 3.794B |
| Gross Profit Margin (Quarterly) | -116.9% |
| Profit Margin (Quarterly) | -1.37K% |
| Earnings Yield | -3.95% |
| Normalized Earnings Yield | -3.967 |